Physician
Gajo, Esperanza
Gajo, Esperanza was paid $8K by Medicaid between Jan 2018 and Dec 2024, across 49 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 99% of everything it billed.
33Billing provider infoGAJO, ESPERANZA
LANCASTER, CA 93536
LANCASTER, CA 93536
33aNPI1760519987assigned 02/27/2007
33bProvider typePediatrics Physician
28Total paid$8K
24GClaims29,388
24DCodes billed49
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in California
Rank by total paid#841 of 1,490
Median peer was paid$15K
This provider vs. median0.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,095 | $4K | |
| 2019 | 1,984 | $3K | |
| 2020 | 3,780 | $0.00 | |
| 2021 | 5,528 | $0.00 | |
| 2022 | 5,404 | $0.00 | |
| 2023 | 4,880 | $0.00 | |
| 2024incomplete | 5,717 | $0.00 |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 99% | 3,463 | 2,874 | $7K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1.1% | 1,982 | 1,722 | $85.08 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 185 | 152 | $18.10 |
| 83036 | Hemoglobin; glycosylated (A1C) | 0% | 2,629 | 2,616 | $0.00 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 0% | 1,825 | 1,717 | $0.00 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 0% | 49 | 49 | $0.00 |
| 36415 | Collection of venous blood by venipuncture | 0% | 5,006 | 4,567 | $0.00 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 349 | 346 | $0.00 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 0% | 1,024 | 1,020 | $0.00 |
| 3079F | 0% | 151 | 146 | $0.00 | |
| 85027 | 0% | 1,007 | 976 | $0.00 | |
| 80053 | Comprehensive metabolic panel | 0% | 2,847 | 2,700 | $0.00 |
37 more codes
| 81000 | 0% | 45 | $0.00 | |
| 80048 | Basic metabolic panel (calcium, ionized) | 0% | 116 | $0.00 |
| 3044F | 0% | 204 | $0.00 | |
| 99214 | Doctor's office visit, returning patient (more involved) | 0% | 771 | $0.00 |
| 86780 | 0% | 162 | $0.00 | |
| 99441 | 0% | 406 | $0.00 | |
| 90656 | 0% | 33 | $0.00 | |
| 99443 | 0% | 24 | $0.00 | |
| 82043 | 0% | 274 | $0.00 | |
| 1220F | 0% | 191 | $0.00 | |
| 81001 | 0% | 167 | $0.00 | |
| 84443 | Thyroid stimulating hormone (TSH) | 0% | 507 | $0.00 |
| 3074F | 0% | 414 | $0.00 | |
| 87205 | 0% | 13 | $0.00 | |
| 1111F | 0% | 206 | $0.00 | |
| 4450F | 0% | 57 | $0.00 | |
| 3075F | 0% | 125 | $0.00 | |
| 90686 | 0% | 60 | $0.00 | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 0% | 53 | $0.00 |
| 1000F | 0% | 73 | $0.00 | |
| 86592 | 0% | 14 | $0.00 | |
| 87088 | 0% | 14 | $0.00 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 0% | 29 | $0.00 |
| 86703 | 0% | 384 | $0.00 | |
| 82274 | 0% | 222 | $0.00 | |
| 80061 | Lipid panel | 0% | 2,275 | $0.00 |
| 3078F | 0% | 479 | $0.00 | |
| 80074 | 0% | 56 | $0.00 | |
| 99442 | 0% | 927 | $0.00 | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 0% | 29 | $0.00 |
| 99203 | Doctor's office visit, new patient (routine) | 0% | 14 | $0.00 |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 0% | 29 | $0.00 |
| 82540 | 0% | 274 | $0.00 | |
| 3077F | 0% | 100 | $0.00 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 0% | 49 | $0.00 |
| 99204 | Doctor's office visit, new patient (more involved) | 0% | 13 | $0.00 |
| 1033F | 0% | 62 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.